Yükleniyor... / Loading...
This study investigated whether response to the medications clomipramine, escitalopram and duloxetine could be predicted in people with obsessive compulsive disorder. It enrolled patients with this diagnosis who were able to swallow tablets. It was conducted as a trial with no assigned phase and has been completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * Clinical diagnosis of Obsessive Compulsive Disorder * Must be able to swallow tablets Exclusion Criteria: * History of stroke * History of Parkinson's disease * History of Epilepsy * Clinical diagnosis of Schizophrenia or schizoaffective disorder * Clinical diagnosis of Bipolar Affective disorder * Active suicidality